• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

毒品法庭系统中的“急诊室”:评估阿片类药物干预法庭

"The Emergency Room" in the Drug Court System: Evaluating the Opioid Intervention Court.

作者信息

Kahn Linda S, Hoopsick Rachel A, Horrigan-Maurer Caroline, Homish Gregory G

机构信息

Primary Care Research Institute, Department of Family Medicine, University at Buffalo, 77 Goodell Street, Suite 220, Buffalo, NY 14203.

Department of Community Health and Health Behavior, School of Public Health and Health Professions, University at Buffalo, 310 Kimball Hall, Buffalo, NY 14214.

出版信息

Vict Offender. 2021 Feb;16(8):1130-1148. doi: 10.1080/15564886.2020.1867277.

DOI:10.1080/15564886.2020.1867277
PMID:39735219
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11672867/
Abstract

The Opioid Intervention Court (OIC) began in Buffalo, NY, in May 2017 as an intensive intervention for people at risk of overdose. We evaluated the OIC focusing on four major aims: (1) To describe OIC participant demographic characteristics, completion, and court engagement, from court administrative data; (2) To examine OIC completion by demographics and court engagement characteristics; (3) To describe participants' OIC experiences from survey data; (4) To explore court team members' perceptions and experiences based on interviews. Results suggest that participants who initiated MAT within the first week were more likely to complete OIC. Participants and personnel responded favorably to the OIC program.

摘要

阿片类药物干预法庭(OIC)于2017年5月在纽约州布法罗市启动,作为对有过量用药风险人群的强化干预措施。我们围绕四个主要目标对阿片类药物干预法庭进行了评估:(1)根据法庭行政数据描述阿片类药物干预法庭参与者的人口统计学特征、结业情况和法庭参与度;(2)按人口统计学和法庭参与度特征检查阿片类药物干预法庭的结业情况;(3)根据调查数据描述参与者在阿片类药物干预法庭的经历;(4)通过访谈探索法庭团队成员的看法和经历。结果表明,在第一周内开始药物辅助治疗(MAT)的参与者更有可能完成阿片类药物干预法庭的项目。参与者和工作人员对阿片类药物干预法庭项目的反响良好。

相似文献

1
"The Emergency Room" in the Drug Court System: Evaluating the Opioid Intervention Court.毒品法庭系统中的“急诊室”:评估阿片类药物干预法庭
Vict Offender. 2021 Feb;16(8):1130-1148. doi: 10.1080/15564886.2020.1867277.
2
Referral to and engagement in substance use disorder treatment within opioid intervention courts in New York: a qualitative study of implementation barriers and facilitators.纽约阿片类药物干预法庭中转介和参与物质使用障碍治疗:实施障碍和促进因素的定性研究。
Subst Abuse Treat Prev Policy. 2024 Jan 29;19(1):12. doi: 10.1186/s13011-024-00593-y.
3
Examining the Impact of the Innovative Opioid Court Model on Treatment Access and Court Outcomes for Court Participants.探讨创新型阿片类药物法庭模式对法庭参与者获得治疗和法庭结果的影响。
J Addict Med. 2024;18(6):635-642. doi: 10.1097/ADM.0000000000001330. Epub 2024 Jun 24.
4
Court personnel attitudes towards medication-assisted treatment: A state-wide survey.法庭工作人员对药物辅助治疗的态度:全州范围的调查。
J Subst Abuse Treat. 2019 Sep;104:72-82. doi: 10.1016/j.jsat.2019.06.011. Epub 2019 Jun 28.
5
Barriers to medications for opioid use disorder in the court system: provider availability, provider "trustworthiness," and cost.法院系统中阿片类药物使用障碍治疗药物的障碍:提供者的可及性、提供者的“可信度”和成本。
Health Justice. 2022 Jul 27;10(1):24. doi: 10.1186/s40352-022-00188-4.
6
Examining Predisposing Factors and Program Performance Indicators Associated With Program Completion: A Comparison of Opioid and Non-Opioid-Preferring Participants in Drug Court.检查与戒毒法院中阿片类药物和非阿片类药物偏好参与者的项目完成相关的诱发因素和项目绩效指标。
Int J Offender Ther Comp Criminol. 2020 Sep;64(12):1236-1257. doi: 10.1177/0306624X19866130. Epub 2019 Aug 1.
7
The Burden of Opioid-Induced Constipation: Discordance Between Patient and Health Care Provider Reports.阿片类药物所致便秘的负担:患者与医疗服务提供者报告之间的差异
J Manag Care Spec Pharm. 2016 Mar;22(3):236-45. doi: 10.18553/jmcp.2016.22.3.236.
8
Criminal problem-solving and civil dependency court policies regarding medications for opioid use disorder.刑事问题解决和民事依赖法庭政策中有关阿片类药物使用障碍的药物治疗。
Subst Abus. 2022;43(1):425-432. doi: 10.1080/08897077.2021.1944958. Epub 2021 Jul 8.
9
Online Medication Assisted Treatment Education for Court Professionals: Need, Opportunities and Challenges.在线药物辅助治疗法庭专业人员教育:需求、机遇与挑战。
Subst Use Misuse. 2021;56(10):1439-1447. doi: 10.1080/10826084.2021.1936045. Epub 2021 Jun 21.
10
"SafetyNet": Evaluation of a Recovery Coach and Paramedic Intervention Following Naloxone Resuscitation From an Opioid Overdose.“安全网”:对阿片类药物过量使用经纳洛酮复苏后康复教练和护理人员干预措施的评估。
Subst Use Addctn J. 2025 Apr;46(2):302-312. doi: 10.1177/29767342241266412. Epub 2024 Aug 22.

本文引用的文献

1
The impact of drug court participation on mortality: 15-year outcomes from a randomized controlled trial.药物法庭参与对死亡率的影响:一项随机对照试验的 15 年结果。
J Subst Abuse Treat. 2019 Oct;105:12-18. doi: 10.1016/j.jsat.2019.07.004. Epub 2019 Jul 18.
2
Recovery From Opioid Problems in the US Population: Prevalence, Pathways, and Psychological Well-Being.美国人口中阿片类药物问题的康复:流行率、途径和心理健康。
J Addict Med. 2020 May/Jun;14(3):207-216. doi: 10.1097/ADM.0000000000000561.
3
Evaluation of Treatment and Other Factors That Lead to Drug Court Success, Substance Use Reduction, and Mental Health Symptomatology Reduction Over Time.对随着时间推移导致药物法庭成功、药物使用减少和心理健康症状减轻的治疗及其他因素的评估。
Int J Offender Ther Comp Criminol. 2019 Feb;63(2):257-275. doi: 10.1177/0306624X18789832. Epub 2018 Jul 30.
4
Only One In Twenty Justice-Referred Adults In Specialty Treatment For Opioid Use Receive Methadone Or Buprenorphine.仅有五分之一被转介接受专科阿片类药物使用治疗的成年司法涉案者接受美沙酮或丁丙诺啡治疗。
Health Aff (Millwood). 2017 Dec;36(12):2046-2053. doi: 10.1377/hlthaff.2017.0890.
5
Medications for opioid use disorder: bridging the gap in care.用于阿片类物质使用障碍的药物:弥合治疗差距。
Lancet. 2018 Jan 27;391(10118):285-287. doi: 10.1016/S0140-6736(17)32893-3. Epub 2017 Nov 14.
6
Development and validation of a Brief Assessment of Recovery Capital (BARC-10) for alcohol and drug use disorder.用于酒精和药物使用障碍的康复资本简短评估量表(BARC - 10)的开发与验证
Drug Alcohol Depend. 2017 Aug 1;177:71-76. doi: 10.1016/j.drugalcdep.2017.03.022. Epub 2017 May 19.
7
Finding the loopholes: a cross-sectional qualitative study of systemic barriers to treatment access for women drug court participants.寻找漏洞:对女性毒品法庭参与者获得治疗的系统性障碍的横断面定性研究
Health Justice. 2015 Dec;3:12. doi: 10.1186/s40352-015-0026-2. Epub 2015 Jun 17.
8
American Society of Addiction Medicine (ASAM) National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use.美国成瘾医学协会(ASAM)关于使用药物治疗阿片类药物使用成瘾的国家实践指南。
J Addict Med. 2015 Sep-Oct;9(5):358-67. doi: 10.1097/ADM.0000000000000166.
9
Medication assisted treatment in US drug courts: results from a nationwide survey of availability, barriers and attitudes.美国毒品法庭中的药物辅助治疗:一项全国性调查对可用性、障碍和态度的结果。
J Subst Abuse Treat. 2013 May-Jun;44(5):473-80. doi: 10.1016/j.jsat.2012.10.004. Epub 2012 Dec 3.
10
The Assessment of Recovery Capital: properties and psychometrics of a measure of addiction recovery strengths.康复资本评估:成瘾康复优势测量的特性和心理计量学。
Drug Alcohol Rev. 2013 Mar;32(2):187-94. doi: 10.1111/j.1465-3362.2012.00489.x. Epub 2012 Aug 10.